Osborne Clarke LLP acts for a varied client roster, notably including BioNTech, Turbine, and Advent Life Sciences. Practice co-head Will James is a patent litigator who regularly acts for biotech, electronics, and medical device companies in disputes; while co-head Matthew Edwards maintains a corporate-focused practice, and advises companies and investors on M&A and venture capital investments. Marcus Vass primarily advises digital health companies on outsourcings and privacy matters. Peter Rudd-Clarke has broad experience in defending product liability claims and handling regulatory compliance issues. Having joined the team from Marks & Clerk in October 2022, Trevor Crosse has deep knowledge of SPC disputes and exclusivity rights.

Legal 500 Editorial commentary

Key clients

  • Santen
  • BioNTech
  • Turbine
  • Basecamp Research
  • King's College London
  • UCL Technology Fund
  • Optellum
  • AviadoBio
  • Advent Life Sciences
  • Ada Digital Health
  • Doctor Care Anywhere
  • Elephant Health
  • Koa Health
  • Thriva
  • Science Creates Ventures

Work highlights

  • Advised BioNTech on its acquisition of InstaDeep Ltd for up to £562m.
  • Advising Amgen on its litigation strategy in respect of the competitive new clinical field of cholesterol-lowering antibodies for the treatment of cardiovascular disease.
  • Advised AviadoBio Ltd on its $80m Series A financing round.

Lawyers

Practice head

The lawyer(s) leading their teams.

Will James, Matthew Edwards, Marcus Vass, Richard Wilkinson

Other key lawyers

Peter Rudd-Clarke, Trevor Crosse